Stockscreener 앱 받기
20.58
8.43%
-1.83
전일 마감가:
$22.41
열려 있는:
$21.96
하루 거래량:
402.12K
Relative Volume:
1.14
시가총액:
$153.60M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-12.55
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
-23.79%
1개월 성능:
-45.22%
6개월 성능:
+55.13%
1년 성능:
+31.54%
1일 변동 폭
$19.62
$22.00
1주일 범위
$19.62
$26.80
52주 변동 폭
$2.622
$65.80
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
VOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
20.52 | 153.60M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.33 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.05 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.90 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.71 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.73 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | 업그레이드 | Stifel | Hold → Buy |
| 2025-06-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | 개시 | Wedbush | Outperform |
| 2022-04-27 | 개시 | Goldman | Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
| 2021-12-03 | 개시 | Robert W. Baird | Outperform |
| 2021-12-02 | 개시 | Oppenheimer | Outperform |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-03-03 | 개시 | Evercore ISI | Outperform |
| 2021-03-02 | 개시 | Goldman | Sell |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Can Vor Biopharma Inc. stock beat analyst upgradesM&A Rumor & Technical Pattern Based Signals - newser.com
Vor Biopharma Inc. stock volume spike explainedWeekly Trend Summary & Long Hold Capital Preservation Tips - newser.com
Applying big data sentiment scoring on Vor Biopharma Inc.July 2025 Recap & High Accuracy Investment Entry Signals - newser.com
Using Python tools to backtest Vor Biopharma Inc. strategiesWeekly Risk Summary & Growth Focused Stock Reports - newser.com
Why Vor Biopharma Inc. stock could benefit from AI revolutionDollar Strength & Verified Chart Pattern Trade Signals - newser.com
Forecasting Vor Biopharma Inc. price range with options data2025 Macro Impact & Breakout Confirmation Trade Signals - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsWeekly Investment Summary & AI Optimized Trade Strategies - newser.com
How institutional ownership impacts Vor Biopharma Inc. stock2025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Vor Biopharma Inc. stock retracement – recovery analysisWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Will Vor Biopharma Inc. stock gain from government policiesEarnings Overview Report & Daily Stock Trend Reports - newser.com
Vor Biopharma Appoints New Chief Medical Officer - TipRanks
Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer - GlobeNewswire
Can a trend reversal in Vor Biopharma Inc. lead to recoveryMarket Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
How currency fluctuations impact Vor Biopharma Inc. stockEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Technical signs of recovery in Vor Biopharma Inc.Weekly Trade Summary & Daily Volume Surge Signals - newser.com
Risk adjusted return profile for Vor Biopharma Inc. analyzedJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Long term hold vs stop loss in Vor Biopharma Inc.Market Volume Summary & Real-Time Buy Zone Alerts - newser.com
Vor Biopharma Inc. stock chart pattern explainedMarket Trend Summary & High Accuracy Swing Trade Signals - newser.com
Combining price and volume data for Vor Biopharma Inc.Weekly Stock Analysis & Real-Time Buy Zone Alerts - newser.com
Using data models to predict Vor Biopharma Inc. stock movementWeekly Risk Report & Weekly Stock Performance Updates - newser.com
Pattern recognition hints at Vor Biopharma Inc. upsideQuarterly Portfolio Report & Long-Term Safe Return Strategies - newser.com
Q3 EPS Estimates for Vor Biopharma Boosted by HC Wainwright - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 124,311 Shares - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 251,518 Shares - MarketBeat
RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Vor Biopharma Inc. - GuruFocus
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
FY2028 EPS Estimates for Vor Biopharma Decreased by Analyst - MarketBeat
Published on: 2025-10-31 05:21:03 - newser.com
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
보 바이오파마 주식 (VOR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 28 '25 |
Sale |
27.42 |
124,311 |
3,408,230 |
1,055,749 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 30 '25 |
Sale |
25.12 |
24,579 |
617,424 |
779,652 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 27 '25 |
Sale |
28.12 |
90,941 |
2,557,261 |
1,180,060 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 23 '25 |
Sale |
28.01 |
76,880 |
2,153,409 |
1,324,346 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 24 '25 |
Sale |
28.01 |
53,345 |
1,494,193 |
1,271,001 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 20 '25 |
Sale |
29.67 |
92,023 |
2,730,483 |
0 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 21 '25 |
Sale |
28.11 |
25,027 |
703,509 |
1,401,226 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 17 '25 |
Sale |
30.25 |
25,717 |
777,987 |
1,178,725 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 20 '25 |
Sale |
30.05 |
11,616 |
349,101 |
1,167,109 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 21 '25 |
Sale |
30.07 |
200 |
6,015 |
1,166,909 |
1.29%
0.56%
자본화:
|
볼륨(24시간):